Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Susanne Saussele, Johan Richter, Joelle Guilhot, Henrik Hjorth-Hansen, Antonio Medina de Almeida, Jeroen J. W. M. Janssen, Jiri Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson-Strömberg, Juan Luis Steegmann, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Martin Müller, Satu Mustjoki, Marc G. Berger, Philippe Rousselot, Martine Escoffre-BarbeJolanta Dengler, Françoise Rigal-Huguet, Nikolas von Bubnoff, Hana Klamova, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Rea, Tim H. Brümmendorf, Gorgine de Greef, Leif Stenke, Franck Emmanuel Nicolini, Laurence Legros, Andreas Burchert, Jaroslava Voglová, Aude Charbonnier, Emmanuel Gyan, Maria-Elisabeth Goebeler, Peter E. Westerweel, Andreas Hochhaus, Markus Pfirrmann, Francois-Xavier Francois-Xavier Mahon

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date10. Dec 2017
Publication statusPublished - 10. Dec 2017
Event59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 - Atlanta, United States
Duration: 9. Dec 201712. Dec 2017

Conference

Conference59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 

Country/TerritoryUnited States
CityAtlanta
Period09/12/201712/12/2017

Cite this